Učitavanje...
Cancer-on-a-chip for modeling immune checkpoint inhibitor and tumor interactions
Cancer immunotherapies, including immune checkpoint inhibitor (ICI)-based therapies, have revolutionized cancer treatment. However, patient response to ICIs is highly variable, necessitating the development of methods to quickly assess efficacy. In this study, an array of miniaturized bioreactors ha...
Spremljeno u:
| Izdano u: | Small |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7939119/ https://ncbi.nlm.nih.gov/pubmed/33502118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/smll.202004282 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|